期刊
CURRENT HYPERTENSION REPORTS
卷 12, 期 4, 页码 233-242出版社
SPRINGER
DOI: 10.1007/s11906-010-0125-3
关键词
Hypertension; Antihypertensive agents; Inflammation; Oxidative stress; Cytokines; Thiazides; Mineralocorticoid receptor blockers; Beta-blockers; Calcium channel blockers; Blockers of the renin-angiotensin system; Endothelin receptor blockers
It is currently accepted that hypertension, atherosclerosis, and diabetes are disorders with subtle or overt activation of inflammatory mediators. Therefore, it has become increasingly important to ascertain whether current antihypertensive drug families have proinflammatory or anti-inflammatory actions that modify the outcomes of their hemodynamic effects on blood pressure. We review the current state of knowledge about the effects of the major classes of available antihypertensive agents on inflammation and speculate on the possible contribution of these effects to observations in clinical trials. We suggest that a strategy of drug development specifically addressing inflammation in hypertension may provide increased benefit in terms of target organ damage, and we describe some examples of these promising developments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据